Zurich Cantonal Bank’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Zurich Cantonal Bank's CSTL Position: Q3 2026 in Review
Zurich Cantonal Bank increased its Castle Biosciences (CSTL) stake by 2.6% in Q3 2026, buying an estimated $12.2K and bringing the position to 15,982 shares worth $568K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.
Zurich Cantonal Bank first reported a position in CSTL in Q3 2020 and has held it in 24 quarters since. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Zurich Cantonal Bank held 15,982 shares of Castle Biosciences worth $568K as of Q3 2026.
- Zurich Cantonal Bank bought 403 Castle Biosciences shares in Q3 2026, an estimated $12.2K.
- Castle Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q3 2026, its #1844 holding.
- Zurich Cantonal Bank first reported a position in Castle Biosciences in Q3 2020 and has held it in 24 quarters since.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Zurich Cantonal Bank's 13F filing for Q3 2026, filed 10 Nov 2026.